{{Rsnum
|rsid=1382269
|Chromosome=3
|position=137389640
|Orientation=plus
|GMAF=0.3669
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 22.1 | 47.8 | 30.1
| HCB | 13.9 | 45.3 | 40.9
| JPT | 8.0 | 48.7 | 43.4
| YRI | 2.0 | 17.7 | 80.3
| ASW | 0.0 | 35.1 | 64.9
| CHB | 13.9 | 45.3 | 40.9
| CHD | 16.5 | 43.1 | 40.4
| GIH | 4.0 | 36.6 | 59.4
| LWK | 1.8 | 11.8 | 86.4
| MEX | 22.4 | 56.9 | 20.7
| MKK | 3.2 | 26.3 | 70.5
| TSI | 25.5 | 51.0 | 23.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19043545
|Trait=Serum metabolites
|Title=Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum
|RiskAllele=
|Pval=5E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs1382269
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19043545; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum. (Initial Sample Size: 284 males; Replication Sample Size: NR); (Region: 3q22.3; Reported Gene(s): Intergenic; Risk Allele: rs1382269-?); (p-value= 0.0000005).This variant is associated with Serum metabolites.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740317
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1382269
|overall_frequency_n=44
|overall_frequency_d=128
|overall_frequency=0.34375
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=38
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}